ZBIO
Common StockZenas BioPharma, Inc.
Reported Shares
2.9M
Position Mix
No options reported
Reported Value
$78.7M
Portfolio Weight
28.14%
Reported 13F portfolio for Q3 2026.
Reported 13F Portfolio Value
$279.8M
Data Refreshed
Nov 17, 2026
Portfolio Structure
Company profiles & logos by Twelve Data
ZBIO
Common StockZenas BioPharma, Inc.
Reported Shares
2.9M
Position Mix
No options reported
Reported Value
$78.7M
Portfolio Weight
28.14%
IMNM
Common StockImmunome Inc.
Reported Shares
3.6M
Position Mix
No options reported
Reported Value
$77.7M
Portfolio Weight
27.79%
BRVE
Common StockBraveheart Bio, Inc.
Reported Shares
3.7M
Position Mix
No options reported
Reported Value
$74.2M
Portfolio Weight
26.53%
SION
Common StockSionna Therapeutics, Inc.
Reported Shares
2.5M
Position Mix
No options reported
Reported Value
$13.0M
Portfolio Weight
4.66%
UPB
Common StockUpstream Bio, Inc.
Reported Shares
2.5M
Position Mix
No options reported
Reported Value
$13.0M
Portfolio Weight
4.63%
BBOT
Common StockBridgeBio Oncology Therapeutics, Inc.
Reported Shares
2.6M
Position Mix
No options reported
Reported Value
$10.8M
Portfolio Weight
3.85%
CMPX
Common StockCompass Therapeutics, Inc.
Reported Shares
7.8M
Position Mix
No options reported
Reported Value
$8.1M
Portfolio Weight
2.90%
CAMP
Common StockCamp4 Therapeutics Corp
Reported Shares
1M
Position Mix
No options reported
Reported Value
$4.2M
Portfolio Weight
1.50%